Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...

DEAR DR. ROACH: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn’t tell us how to ...

Findings showed BDP/FF/G improved predose FEV1 and reduced the rate of moderate to severe exacerbations compared with BDP/FF. The Food and Drug Administration (FDA) has accepted for review the New ...

Inhalers that provide fast-acting treatment for people with certain respiratory conditions are contributing to greenhouse gas emissions, which can worsen both climate change and the conditions ...

Inhalers that deliver quick relief to patients with asthma and chronic obstructive pulmonary disease (COPD) may be taking a toll on the planet, producing as much climate-warming pollution as more than ...

(NEXSTAR) – That small whoosh from an inhaler has a substantial environmental toll that could be putting some people with chronic conditions at risk, according to a new study. Published Monday in the ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

The people who are most vulnerable to the hard-to-breathe air that comes with climate change may inadvertently be adding to the problem, new research finds. About 34 million Americans have a chronic ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...

Inhalers that combine providing immediate relief with a longer-term preventative effect are already recommended as the standard treatment for mild asthma among people aged 12 and above in the UK, US ...